Related Experiment Video
Updated: Jun 15, 2026

10:46
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
Nanoparticle-aptamer conjugates for cancer cell targeting and detection
M Carmen Estévez1, Yu-Fen Huang, Huaizhi Kang
1Department of Chemistry, Functional Genomics Shands Cancer Center, Center for Research at the Bio/Nano Interface, University of Florida, Gainesville, FL, USA.
Methods in Molecular Biology (Clifton, N.J.)
|March 11, 2010
Summary
Researchers developed novel aptamers using cell-SELEX to target leukemia cells. These aptamers, when conjugated with magnetic and fluorescent nanoparticles, offer a sensitive method for cancer cell detection and enrichment.
Area of Science:
- Biotechnology
- Molecular Biology
- Nanotechnology
Background:
- Aptamers are oligonucleotide sequences selected for high-affinity binding to specific targets.
- Cell-SELEX enables the selection of aptamers that recognize whole living cells.
- Existing methods for cancer cell detection require improvement in sensitivity and specificity.
Purpose of the Study:
- To generate aptamers targeting acute leukemia cells (CCRF-CEM) using cell-SELEX.
- To enhance aptamer selectivity and sensitivity through conjugation with a dual-nanoparticle system.
- To evaluate the potential of this aptamer-nanoparticle system for rapid, low-cost cancer diagnostics.
Main Methods:
- Selection of aptamers against CCRF-CEM cells via cell-SELEX.
- Conjugation of selected aptamers with magnetic nanoparticles (MNP) for cell enrichment.
- Coupling of aptamers to fluorescent silica nanoparticles (FNP) for sensitive detection.
- Validation using confocal microscopy and fluorescence microplate reader.
Main Results:
- Aptamers with nanomolar dissociation constants were generated for leukemia cells.
- The MNP-aptamer conjugate enabled selective cell collection and enrichment from complex matrices.
- The FNP-aptamer conjugate allowed highly sensitive detection of cancer cells.
- Specific cell collection and detection were confirmed at concentrations as low as 250 cells.
Conclusions:
- The developed aptamer-nanoparticle system demonstrates high affinity and specificity for cancer cells.
- This approach offers a promising rapid, low-cost method for cancer cell detection and enrichment.
- The dual-nanoparticle system enhances diagnostic capabilities for leukemia and potentially other cancers.
More Related Videos
Related Concept Videos
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...

